Indogulf Cropsciences Earnings Call Transcript: Key Takeaways
Q2 revenue +3% to ₹255.8 Cr; EBITDA +27%, margin 16% (13%) on mix and cost cuts. H1 revenue -3%, negative operating cash flow, inventory elevated.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
31 announcements with these filters
Q2 revenue +3% to ₹255.8 Cr; EBITDA +27%, margin 16% (13%) on mix and cost cuts. H1 revenue -3%, negative operating cash flow, inventory elevated.
Indogulf Cropsciences reported Q2 FY27 EBITDA of ₹41 Cr (up 27%) and PAT of ₹26 Cr (up 24%). Margin expanded 300 bps to 16% on favourable product mix.
Indogulf Cropsciences filed its Monitoring Agency Report for the quarter ended September 30, 2026, covering IPO proceeds of Rs 200 crore. The report states no deviation from the objects of the issue.
Q2 FY27 revenue up 3% YoY to INR 2,558 Mn; EBITDA up 27% to 406 Mn (15.9% margin); PAT up 24% to 257 Mn. H1 revenue down 3%.
Indogulf Cropsciences Ltd reported revenue from operations of ₹255.8 Cr (+3.0% YoY) and net profit of ₹25.7 Cr (+24.2% YoY) for Q2 FY27.
Indogulf Cropsciences will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window closes from 1 October 2026.
The company submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per Regulation 31 of SEBI Listing Regulations.
Indogulf Cropsciences re-appointed Pushap Kumar as Non-Executive Director and appointed M/s NJ & Associates as Secretarial Auditor for five years.
Indogulf Cropsciences Limited announced the re-appointment of Mr. Pushap Kumar as Non-Executive Non-Independent Director and the appointment of M/s. NJ & Associates as Secretarial Auditor.
Indogulf Cropsciences Ltd. conducted its 34th Annual General Meeting. Shareholders approved financial statements, director re-appointment, auditor matters, and variation in IPO proceeds utilization.
Indogulf Cropsciences Ltd has filed its Annual Report for FY2025-26. The 34th Annual General Meeting is scheduled to be held on September 24, 2026.
Indogulf Cropciences Limited has issued the notice for its Annual General Meeting to be held on September 24, 2026. The meeting will transact five business agenda items.
Indogulf Cropsciences won a High Court ruling against a Rs. 8.48 Crore GST demand. The court squashed the recovery notice, entitling the company to a refund.
Indogulf Cropsciences reported Q1 FY27 revenue of INR 1,685 Mn and PAT of INR 24 Mn, focusing on transitioning from products to an integrated agri-solutions platform.
Indogulf Cropsciences reported Q1 FY27 revenue of ₹168.5 Crore. The company highlighted improvements in operational efficiency and growth in its integrated agri-solutions portfolio.
Indogulf Cropsciences Ltd reported revenue from operations of ₹168.5 Cr (-11.0% YoY) and net profit of ₹2.4 Cr (-38.5% YoY) for Q1 FY27.
Indogulf Cropsciences Limited has scheduled a board meeting on August 12, 2026, to consider and approve its standalone and consolidated financial results.
Indogulf Cropsciences Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI regulations.
The filing discloses the shareholding pattern of INDOGULF CROPSCIENCES LIMITED per Regulation 31(1)(b). No monetary or transactional details are provided.
Indogulf Cropsciences' Managing Director Sanjay Aggarwal received the 17th Visionary Leadership Award 2026. The award underscores the company's commitment to sustainable agriculture.
Indogulf Cropsciences reported 19% YoY revenue growth in FY26, driven by a diversified product mix and domestic expansion. PAT grew 27% YoY due to higher-margin specialty products and operating leverage.
Indogulf Cropsciences appointed T Jain & Associates as Internal Auditors and Jain Sharma and Associates as Cost Auditors. Both firms are appointed for a 12-month term.
Indogulf Cropsciences reported FY26 revenue of ₹704.6 Crore, up 19% YoY. Net profit grew 27% to ₹40 Crore, driven by export expansion and distribution growth.
Indogulf delivered strong FY26 performance with 19% revenue growth and 27% PAT growth, driven by its Crop Protection vertical and expansion into new international markets.
Indogulf Cropsciences Ltd reported revenue from operations of ₹150.8 Cr (+19.5% YoY) and net profit of ₹11.6 Cr (+18.4% YoY) for Q4 FY26.
Indogulf Cropsciences approved its FY26 audited financial results, reporting standalone annual revenue of ₹6,755.07 Million. The board also recommended secretarial and cost auditor appointments for upcoming periods.
Indogulf Cropsciences scheduled a May 28 board meeting to approve fiscal 2026 audited results. An earnings call will follow on May 29.
Indogulf Cropsciences Limited reported zero deviation in utilizing its ₹160 Crore IPO proceeds for the quarter ended March 2026. The funds support working capital and capacity expansion.
Indogulf Cropsciences Ltd submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by NJ & Associates, confirms compliance with SEBI regulations. The company noted that prior year reporting was not applicable as it listed on July 3, 2025.
Indogulf Cropsciences Limited has appointed NJ and Associates as its secretarial auditor effective April 7, 2026. NJ and Associates is a Delhi-based firm established in 2016, specializing in legal, secretarial, and advisory services. This appointment ensures the company's continued compliance with statutory audit requirements.